A randomized, prospective, controlled study has compared 1 % etidocaine (E) in nineteen patients and 0.5% bupivacaine (B) in 22 patients when used with 1/200,000 adrenaline for epidural blockade. There were unexpected similarities in onset profiles for the two agents, however etidocaine produced a superior intensity of sensory and motor blockade without increased toxicity.
INTRODUCTION
The spectrum of local anaesthetic drugs presently available includes a rapid onset but short duration agent (lignocaine) and a slower onset, longer duration agent (bupivacaine) . Both agents used in appropriate concentration can produce satisfactory sensory block for the entire range of regional block techniques. In epidural anaesthesia, motor blockade is minimal after 2 % lignocaine plain (Bromage et al. 1964) or 0.5% bupivacaine plain and only moderate after 0.5 % bupivacaine with adrenaline (Bromage and Gertel 1970) , while excellent motor blockade of short duration is produced by 2 % lignocaine with adrenaline . The spectrum of local anaesthetics for epidural block lacks an agent with rapid onset and long duration of sensory block combined with satisfactory long lasting muscle relaxation.
Etidocaine (Duranest R ) was developed to fill this need. In particular, it was hoped that this agent would provide more rapid and more intense sensory blockade and profound muscle relaxation, which, in combination, would produce ideal conditions for abdominal surgery.
Since the subtleties of comparative analgesia and muscle relaxation are so subject to observer bias, the present study was designed as a controlled evaluation of onset profiles of motor, sensory and sympathetic bloc~ade ~or 1 % etidocaine compared to 0.5% buplvacaIne when used for abdominal surgery. Studies of plasma concentrations for both. dru.gs were also carried out as well as determInatIOn of some urinary metaboIites of etidocaine. METHOD A randomized, prospective, controlled design was chosen with triple blind drug administration. Ampoules were specially made up and coded with a random distribution between bupivacaine and etidocaine. Solutions employed were as follows -
(1) 0.5 % bupivacaine wi~h 1/200,000 adrenaline (2) 1 % etidocaine with 1/200,000 adrenaline The code for drug identification was not broken until the study was completed; however, a sealed copy of the code was available at all times should clinical factors warrant that it be opened.
. Forty-one patients scheduled for epIdural block for elective abdominal surgical procedures were studied; those with atherosclerosis or other severe systemic disease were excluded as were patients on chronic drug therapy of any type. Pre-operatively, all pati.ents ~ad a full biochemical screen (SMAI2), IncludIng blood sugar; full blood counts were also carried out, as well as clotting and bleeding studies. Patients with abnormalities in blood determinations were not accepted into !che study.
. Premedication consisted of 10mg dIazepam intramuscularly two hours pre-operatively. An intravenous infusion of 10 ml/kg Hartmann's solution was commenced one and a half hours prior to operation. An 18g epi?ural need.le w~s inserted at LI-L~ interspace WIth the patIent In the riaht lateral position. Mean doses of 12.8 ± 0.5 and 13.1 ± 0.6 ml of local anaesthetic was injected via the needle for group 1 and 2 respectively; minor adjustments in dosage ,:"ere made for each patient, based on age and heIght. Blood pressure was measured by sphygmomanometry and pulse rate by palpation, at five minute intervals prior to and following block. The same trained observer chartered onset pro-files for sympathetic, sensory and motor block as follows:-Sympathetic Block: Continuous recordings of skin temperature of bot>h great toes were made with a dual tele-thermometer. Capillary pulse amplitude was also recorded continuosly with a plethysmograph place.d on the great t?e; pulse amplitude was determIned by measunng the maximum pulse wave height (cm).
Sensory Block: Initial onset time was taken as the time when pin prick sensation was lost in any dermatome. However, onset of complete loss of all touch sensation. wa~ also charted in an endeavour to determIne If one of the two agents was capable of more effective neural penetration. Thus, loss of pin prick sensation with persistence of touch was charted as partial sensory blockade; loss of both touch and pin prick sensation was charted as complete sensory blockade. Tests were carried out each minute for ten minutes, then every five minutes.
Motor Block: Onset was charted at five minute intervals by assessing loss of muscle activity at each joint in the lower limb. ~he degree of blockade was scored ?y assessl?g each major joint in each lower lImb: parttal motor blockade was defined as any reduction in strength at a lower limb joint, with a score of one for each joint partially blocked, i.e. total 0 to 6. Complete motor blockade was defined a complete inability to move at anyone joint -again with a sc,?re of one for each joint completely blocked, I.e. again a total of 0 to 6 ( Table 1) . Abdominal muscle relaxation was also assessed by measurements of abdominal girth, at a fixed point, at full inspiration and full expiration, prior to blockade and a maximal limb joint blockade. Plasma Concentration and Metabolism Studies: Studies of plasma level profile for etidocaine and bupivacaine were carried out using a cubital central venous catheter with intermittent heparin flush. Samples were obtained, five minutes apart for one hour, half hourly for three hours, then hourly for twelve hours. Metabolism of etidocaine was studied by collecting twenty-four hour urine samples preoperatively and then for two days post operatively.
Analytical Techniques for measurement of plasma concentrations of etidocaine and bupivacaine were as described previously: Etidocaine metabolites were assayed by gas chromatography; metabolite structure was determined by gas chromatography /mass spectrometry (Thomas et al. 1976 ). Blood/plasma etidocaine concentration ratios and proportions of free drug in plasma and plasma water were determined in vitro.
Data Analysis: Onset profiles were determined for eaoh drug by calculating mean values (± SEM) of dermatomes blocked at each time interval following epidural injection. A comparison of onset of neural blockade for etidocaine and bupivacaine was made at each time interval using Student's t test. Mean blood pressure and heart rate changes (± SEM) at Non parametric analyses were also carried out. These revealed essentially the same significant differences as obtained with the Student's t test.
Results are presented using the latter method.
RESULTS
Patient characteristics and dose of local anaesthetic agent were similar in both groups ( Table 2 ). There were no significant changes in biochemical variables after epidural block with either agent.
Onset times for sympathetic block and magnitude of sequelae of sympathetic block were very similar for both agents (Table 3, Figure  1 ). The timing of blood pressure changes closely paralleled onset of sympathetic b!ockade; maximum sympathetic block, judged by capillary pulse amplitude, and maximum fall in blood pressure both occurred at approximately twenty minutes post injection (Table 3) . Initial sensory onset in any segment and time to complete spread of partial blockade was surprisingly similar for the two drugs (Table 4 ). However, there were striking differences between the two drugs for onset of complete sensory block: 17.7 ± 1.7 minutes for etidocaine (E) compared to 36.8 ± 3.5 minutes for bupivacaine (B). Spread of analgesia into four segments above and below the injection site was also more rapid for etidocaine both for partial block, E = 12.4 ± 2.8 minutes; B = 30.4 == 4.3 minutes and for complete block, E = 23.1 ± 2.3 minutes; B = full block only obtained in two patients. Onset of partial block of S, was much more rapid with etidocaine; in addition only two patients achieved complete S, block after bupivacaine compared to all but three patients after ctidocaine (Table 4 ).
The number of spinal segments with complete neural blockade was significantly greater for etidocaine compared to bupivacaine from fifteen minutes after injection onwards; the difference between the two drugs became progressively greater until thirty minutes post injection ( Figure 2 ). At twenty minutes post injection etidocaine had achieved full blockade in 16.5 ± 2.3 segments (counting segments on right and left sides) compared to only 5.8 ± 1.9 segments for bupivacaine ( Figure 2 ).
Complete blockade of each spinal segment on both right and left sides also occurred much more rapidly for etidocaine and the extent of Etidocaine blocked significantly more spinal segments from fifteen minutes onwards; this difference increased until thirty minutes post block. Since segments from both sides of the body are plotted, the mean segmental spread is approximately half, e.g. at twenty minutes etidocaine blocked a total of 16.5 ± 2.3 segments or approximately eight segments (see also Figure 3 ). bilateral complete blockade was much greater (Figure 3 ). The percentage of patients with complete bilateral blockade at each level also was markedly greater for etidocaine ( Figure  3 ): for etidocaine all patients achieved complete blockade for two segments on either side of the injection site whereas for bupivacaine this was achieved in only 30-50% patients.
Onset of motor blockade was not significantly different for etidocaine (5.8 ± 0.8 1978 minutes) compared to bupivacaine (8.0 ± 1.2 minutes). However complete spread of motor blockade was much more rapid for etidocaine: etidocaine = 14.7 ± 2.8 minutes; bupivacaine = 28.9 ± 2.8 minutes ( Table 5 ). Degree of motor blockade, assessed by scoring all three joints in both lower limbs (total six) was much greater for etidocaine which resulted in more lower limb joints with complete blockade, from ten minutes after blockade onwards. By twenty minutes post injection, etidocaine had produced full blockade in four out of the six lower limb joints and the remaining two joints had partial blockade; in comparison, bupivacaine produced full blockade at only one lower limb joint joint (Figures 4 and 5) . Abdominal motor blockade, assessed by the abdominal muscle girth technique, was also more profound for etidocaine (Table 5) .
Peak plasma concentration of etidocaine occurred approximately twenty minutes after injection ( Figure 6 ). Mean peak concentration was 0.8 ± 0.1 p,g/ml for E and 0.7 ± 0.1 p,g/ml for B. Plasma protein binding and fraction of free etidocaine are shown in Table 6 ; etidocaine was more rhan 90% bound to plasma proteins, so that the amount of free drug was quite small.
A gas chromatogram of etidocaine and some of its metabolites is shown in Figure 7 . Gas chromatography and subsequent mass spectrome try identified five separate metabolites with two gas chromatographic peaks remaining unidentified. The identified metabolites were xylidides and xylidine derivatives and it was estimated that over 90% of a dose of etidocaine was metabolized.
DISCUSSION
There have been only a few randomized, prospective controlled studies of the clinical pharmacology of local anaesthetics (Bridenbaugh et al. 1974 , Engberg et al. 1974 . In deciding wherher a new agent has any advantages over existing agents, elimination of observer bias is of prime importance for local anaesthetic drugs; however, while the "trained observer" has been used in studies of narcotic analgesics (Houde et al. 1960 ) this approach appears to have been rare in studies of neural blockade. Furthermore, few studies of local anaesthetics have followed the example of Gunther and Bauman (1969) in the use of coded ampoules of standard and test drug. The clinical efficacy of a local anaesthetic should be defined in l'he context in which it is intended to be used. Thus for example, an agent to be used for obstetric analgesia may be required only to produce satisfactory analgesia with minimal or no motor blockade (Bromage et al. 1974a ). On the other hand, an agent or solution to be used for abdominal surgery would be required to produce excellent muscle relaxation and, ideally, complete loss of all sensation. The usual methods of assessment of sensory blockade vary considerably from loss of pin prick sensation to loss of sensation of pinch by a forceps. Most patients prefer to have no sensation at all in the operative area regardless of whether "it will feel similar to a touch but will not be painful". Thus in the present study efficacy of sensory blockade for abdominal surgery was assessed by determining the rapidity and extent of spread of complete sensory block and the continuity of segmental block on both sides of the body. SimiJ~r1y for motor block, the rapidity and extent of spread of complete blockade was charted and an attempt was made to determine if blockade was continuous on both sides of the body and in adjacent segments above and below. Using a controlled study design and appropriate criteria for efficacy of blockade, the present study has demonstrated considerably improved efficacy of 1 % etidocaine compared to 0.5 % bupivacaine when both drugs are used with adrenaline for epidural block in patients requiring abdominal surgery. The data also indicate a superiority of etidocaine for patients requiring rapid and profound sensory and motor block for lower limb surgery. The foregoing would, of course, be to no avail if the toxicity of 1 % etidocaine exceeded that of 0.5% bupivacaine to the same extent as its increased efficacy. Until recently, precise data in man concerning the relative toxicity of local anaesthetics has not been available. Knowledge of the pharmaco-kinetics and toxicity of these drugs now indicates that the arterial plasma concentration of etidocaine at which detectable toxic effects begin is in excess of 3.0 Ilg/ml. In the present study, a dose of approximately 130 mg etidocaine resulted in a mean peak plasma concentration of 0.8 ± 0.1 Ilg/ml compared to 0.7 ± 0.1 Ilg/ml for a dose of 65 mg bupivacaine. These results are in keeping with previous reports of maximum mean arterial plasma concentrations of 1.5 Ilg/ml after a dose of 300 mg etidocaine and 1.4 Ilg/ml after a dose of 150 mg bupivacaine ). Tucker and Mather (1975) FIGURE 5,-Onset of complete motor blockade. Joint score for complete blockade (see text) is plotted at each time interval. Onset of complete blockade was more rapid for etidocaine. The number of joints with complete blockade was significantly greater for etidocaine from ten minutes after blockade onwards. estimated a ctox/cmax* ratio of 1.9 for bupivacaine 0.5% compared to 2.7 for 1 % etidocaine. Using intravenous infusion in volunteers, Scott (1975) found that central nervous system toxicity did not occur with slow infusion of etidocaine when venous plasma concentrations exceeded 1. block. Scott (1975) also reported that bupivacaine had a toxic potential whioh was 1.4-2.1 times greater than etidocaine. In the current study, plasma levels of etidocaine and bupivacaine were similar when the dose of etidocaine was double that of bupivacaine, thus the toxic potential would appear to be similar to that reported by Scott. However the situation of unexpected intravascular injection should also be considered: the similar plasma concentrations of etidocaine and bupivacaine w (j) z 0 0... obtained in the present study are in keeping with the greater clearance and volume of distribution of etidocaine (Tucker and Mather, 1975) . This would be expected to offer a major advantage in reducing 1!he duration and severity of toxicity after inadvertent intravascular injection of etidocaine compared to bupivacaine. The extensive plasma protein binding of etidocaine demonstrated in the current study (Table 6 ) is similar to that previously reported and is essentially the same as for bupivacaine (Tucker and Mather 1975) and thus would result in a similar fraction of free drug of approximately 0.05 in plasma. This fraction of the drug is available for transfer to the central nervous system and thus the high plasma binding of both of these long-acting drugs confers a safety feature. The metabolism of etidocaine is extensive, as indicated in Figure 6 and the five identified metabolites are either xylidine or butyroxylidide compounds. To date there is no evidence that these are more toxic than etidocaine. Although the metabolite species of etidocaine are markedly different to those of lignocaine, the hepatic extraction ratios for etidocaine (0.81) and lignocaine (0.63) are similar compared to the lower ratio of 0.31 for bupivacaine (Tucker and Mather 1975) . Although it would appear to be possible to increase the concentration (and thus dose) of bupivacaine to achieve more profound blockade, this would result in an unacceptable narrowing of the margin between blood level associated with effective epidural block and the toxic blood level. Thus, in the present study, improved efficacy of 1 % etidocaine is obtained without increase in toxicity. Moreover, increasing the concentration of bupivacaine to 1 % would be unlikely to provide the same degree of efficacy as 1 % etidocaine despite a considerable increase in toxicity.
The onset profile and magnitude of sequelae of sympathetic block were surprisingly similar for the two agents. Both drugs took approximately seven minutes to produce an initial rise in skin temperature or capillary pulse amplitude. The maximum change in capillary pulse amplitude occurred at approximately twenty minutes post block for both drugs and this coincided with the maximum fall in mean arterial pressure (Table 3) . It is of interest to note that the onset time of sensory blockade, by t:he methods employed, was not significantly different to that of sympathetic blockade.
This tends to refute the classic view that onset of sympathetic blockade precedes sensory Anaesthesia and Intensive Care. Vol. VI, No. 2, May, 1978 blockade, although it is possible that earlier sympathetic blockade may have been undetected with the methods employed in this study. Sympathetic blockade resulting from longacting local anaesthetics has previously been shown to be at variance with the classic view in that offset of sympathetic blockade of etidocaine occurs 30% earlier than sensory blockade .
Initial studies of etidocaine's sensory blockade had reported that onset of loss of pin prick sensation was more rapid for etidocaine compared to bupivacaine (Lund et al. 1973) . The present study has shown that initial onset of sensory blockade and time to complete spread of partial sensory blockade are very similar for the two drugs ( Table 4 ). The latter finding is in agreement with the crossover volunteer study of ; however, in the present study, spread of complete sensory block occurred more rapidly for etidocaine (29.1 -+-2.3 minutes) compared to bupivacaine (42.3 ± 3.3 minutes). The time required for spread of both partial and complete sensory block for four segments above and below the injection site was also much shorter for etidocaine (Table  4 ). The spread of complete sensory blockade for four segments above and below the injection site would be expected to give a very adequate indication of readiness for abdominal surgery. In the present study this was achieved in just over twenty minutes following etidocaine whereas this spread and intensity of blockade was not consistently achieved following bupivacaine.
Blockade of SI segment is known to be difficult because of its relative size (Galindo et al. 1975) . Here, once again, etidocaine showed considerable advantage, achieving partial block in all patients and complete block in all but three patients (Table 4 ). Bupivacaine took twice as long to aohieve partial blockade and achieved full blockade in only two patients.
Simultaneous presentation of a time-segment diagram and a histogram for the number of patients with full blockade bilaterally in each segment shows the superior neural penetration of etidocaine in best focus (Figure 3) . Impressively, etidocaine achieved complete bilateral blockade in 100% of patients for two segments on either side of the injection site; in excess of 70% of patients had complete blockade for eight adjacent segments. The percentage of patients with complete blockade following bupivacaine was strikingly small; only 30% of patients had full blockade for four adjacent segments. As expected from above, the number of segments with full blockade at each time interval was much greater for etidocaine; this difference was statistically significant from fifteen minutes post block onwards (Figure 2) .
MOTOR BLOCK was more rapid for etidocaine compared to bupivacaine with respect to time to complete spread of blockade (Table  5) . Interestingly, for etidocaine the time to initial onset of motor blockade was very similar to that of onset of sympathetic block. Significant abdominal motor blockade was detectable only for etidocaine, when assessed by the abdominal girth technique (Table 5 ). This more profound blockade was confirmed when partial and complete blockade at lower limb joints was examined; from twenty minutes post block onwards, etidocaine had produced complete block in four of the six joints of the two lower limbs and the remaining two joints had partial blockade (Figures 4 and 5) . In comparison, bupivacaine produced complete block in only one joint at this time. Thus it can be seen that at twenty minutes post injection, etidocaine had produced a solid band of complete bilateral sensory loss for two segments above and below the injection site in all patients and this was accompanied by a profound degree of motor blockade. As mentioned above, this timing also coincided with maximum sympathetic block and maximum fall in blood pressure.
A disadvantage of etidocaine has previously been reported to be the prolonged motor blockade (Bridenbaugh et al. 1974) which is unnecessary in the post-operative period following surgery of short duration but which would be useful during surgery of longer duration. Also, even the lower concentrations of etidocaine are reported to be associated with a profound degree of motor blockade but poor quality sensory blockade; Bromage (1974a) has referred to this as "sensory/motor dissociation". Of importance in surgical anaesthesia, the present study has provided objective evidence that I % etidocaine is capable of very reliable spread of complete sensory blockade compared to bupivacaine. Previous single agent studies of 1% etidocaine have reported a lack of "missed" dermatomal segments (e.g. Bromage ct al. 1974b) . A possible drawback of the sensory block of etidocaine was initially thought to be lack of complete visceral anaesthesia despite a level of segmental blockade sufficient to obtund splanchnic inflow (Bromage et al. 1974b) . However subsequent double-blind studies have revealed that inadequate visceral anaesthesia occurs with equal frequency following epidural block using a wide range of local anaesthetic drugs and is apparently unrelated to agent, drug dose, concentration or level of sensory block (Bridenbaugh et al. 1974) . The most likely explanation appears to be visceral pain mediated by vagal afferents which of course lie wholly outside the vertebral canal (MacIntosh and Bryce-Smith 1962) . This degree of visceral pain is readily obtunded by very light general anaesthesia or alternatively by appropriate supplementation with intravenous sedative and narcotic drugs.
In conclusion, 1% etidocaine appears to have a limited, though valuable, place in the presently available spectrum of local anaesthetic drugs. When used for epidural block it is capable of more rapid and intense sensory and motor blockade which is associated with no increase in systemic toxicity compared to 0.5 % bupivacaine. This superior sensory and motor blockade is ideal for operative surgery of abdomen or lower limbs. However the intensity and duration of motor blockade limits this application to surgery in excess of 1-1--2 hours and indicates the unsuitability of the drug for post-operative analgesia or obstetric analgesia.
